| Literature DB >> 31439024 |
Azra Ramezankhani1, Kamran Guity2, Fereidoun Azizi3, Farzad Hadaegh4.
Abstract
BACKGROUND: We investigated whether metabolic risk factors in one spouse were associated with an excessive risk of type 2 diabetes in the other.Entities:
Keywords: Metabolic risk factors; Spouse; Type 2 diabetes
Mesh:
Year: 2019 PMID: 31439024 PMCID: PMC6704543 DOI: 10.1186/s13293-019-0255-5
Source DB: PubMed Journal: Biol Sex Differ ISSN: 2042-6410 Impact factor: 5.027
Baseline characteristics of index individuals stratified by sex; Tehran Lipid and Glucose study (TLGS) (1999–2018)
| Men | Women | |
|---|---|---|
| Continuous variables | ||
| Age (years) | 45.8 (12.3) | 39.7 (11.1) |
| BMI (kg/m2) | 26.1 (3.7) | 27.6 (4.5) |
| Waist circumference (cm) | 89.9 (10.3) | 87.3 (11.6) |
| SBP (mmHg) | 119.1 (17.1) | 115.1 (16.9) |
| DBP (mmHg) | 77.7 (10.8) | 76.5 (10.3) |
| FPG (mmol/L) | 5.07 (0.5) | 4.9 (0.5) |
| 2 h-PLPG (mmol/L) | 5.8 (1.7) | 6.1 (1.5) |
| TG (mmol/L) | 2.1 (1.3) | 1.7 (1.0) |
| HDL-C (mmol/L) | 0.4 (0.1) | 0.5 (0.1) |
| TG/HDL-C | 5.4 (4.7) | 3.6 (2.9) |
| Categorical variables | ||
| Spousal diabetes | 157 (8.5) | 215 (11.0) |
| SES | ||
| < 6 years of schooling | 330 (18.0) | 350 (17.9) |
| 6–12 years of schooling | 1088 (59.3) | 1175 (60.1) |
| > 12 years of schooling | 415 (22.6) | 427 (21.8) |
| Family history of diabetes | 457 (24.9) | 538 (27.6) |
| Prevalent CVD | 90 (4.9) | 50 (2.6) |
| Smoking status | ||
| Never | 1005 (54.8) | 1853 (94.9) |
| Past | 270 (14.7) | 31 (1.6) |
| Current | 558 (30.4) | 68 (3.5) |
| Physical activity level | ||
| Low physically active | 450 (24.5) | 529 (27.1) |
| Lipid-lowering medication use | 35 (1.9) | 45 (2.3) |
| Antihypertensive medication use | 72 (3.9) | 107 (5.5) |
Values are presented as mean (standard deviation) for continuous variables and, frequency (percent) for categorical variables
BMI body mass index; CVD cardiovascular disease; FPG fasting plasma glucose, SBP systolic blood pressure; DBP diastolic blood pressure; TG/HDL-C triglyceride to high-density lipoprotein cholesterol ratio; 2 h-PLPG 2 h post load plasma glucose; SES socioeconomic status defined as the highest level of educational attainment, at the couple level; SD standard deviation
Baseline characteristics of respondents and non-respondents stratified by sex; Tehran Lipid and Glucose study (TLGS) (1999–2018)
| Women | Men | |||||
|---|---|---|---|---|---|---|
| Variables | Respondent | Non-respondent | Respondent | Non-respondent | ||
| Age (years) | 39.7 (11.1) | 38.9 (11.6) | 0.173 | 45.8 (12.3) | 46.5 (13.4) | 0.248 |
| BMI (kg/m2) | 27.6 (4.5) | 28.2 (5.1) | 0.022 | 26.1 (3.7) | 25.9 (4.1) | 0.250 |
| Waist circumference (cm) | 87.3 (11.6) | 88.4 (12.3) | 0.066 | 89.9 (10.3) | 89.1 (10.9) | 0.092 |
| SBP (mmHg) | 115.1 (16.9) | 115.3 (18.8) | 0.851 | 119.1 (17.1) | 119.9 (18.8) | 0.354 |
| DBP (mmHg) | 76.5 (10.3) | 75.8 (11.2) | 0.183 | 77.7 (10.8) | 78.1 (11.4) | 0.575 |
| TG/HDL-C | 3.6 (2.9) | 3.9 (4.2) | 0.085 | 5.4 (4.7) | 5.2 (4.2) | 0.411 |
| FPG (mmol/L) | 4.9 (0.5) | 4.9 (0.5) | 0.940 | 5.1 (0.5) | 5.1 (0.5) | 0.975 |
| Education | ||||||
| < 6 years of schooling | 549 (28.1) | 178 (28.8) | 0.878 | 452 (24.6) | 185 (27.1) | 0.457 |
| 6–12 years of schooling | 1225 (62.8) | 381 (61.7) | 1044 (57.0) | 375 (54.9) | ||
| > 12 years of schooling | 178 (9.1) | 59 (9.5) | 337 (18.4) | 123 (18.0) | ||
| Family history of diabetes | 538 (27.6) | 170 (27.5) | 0.975 | 457 (24.9) | 164 (24.0) | 0.634 |
| Prevalent CVD | 50 (2.6) | 17 (2.8) | 0.773 | 90 (4.9) | 52 (7.6) | 0.011 |
| Smoking status | ||||||
| Never | 1854 (95.0) | 577 (93.5) | 0.361 | 864 (47.1) | 374 (54.8) | < 0.001 |
| Past | 30 (1.5) | 14 (2.2) | 240 (13.1) | 101 (14.7) | ||
| Current | 68 (3.5) | 27 (4.3) | 729 (39.8) | 208 (30.5) | ||
| Physical activity level | ||||||
| Low physically active | 1421 (72.8) | 472 (76.4) | 0.090 | 1338 (72.9) | 464 (67.9) | 0.666 |
| Lipid-lowering medication | 30 (1.5) | 13 (2.1) | 0.368 | 20 (1.1) | 8 (1.2) | 0.833 |
| Antihypertensive medication | 85 (4.4) | 31 (5.0) | 0.505 | 64 (3.5) | 35 (5.1) | 0.061 |
Mean (SD) are shown for continuous variables and P value is calculated with t test; frequency (%) are shown for categorical variables with P value based on chi-square test
BMI body mass index, CVD cardiovascular disease, FPG fasting plasma glucose, SBP systolic blood pressure, DBP diastolic blood pressure, TG/HDL-C triglyceride to high-density lipoprotein cholesterol ratio, SD standard deviation
The influence of spousal risk factors on type 2 diabetes development; Tehran Lipid and Glucose study (TLGS) (1999–2018)
| Spousal risk factor | Model 1 | Model 2 | Model 3 | Model 4 |
|---|---|---|---|---|
| Men ( | ||||
| BMI (kg/m2) | 1.02 (1.00–1.05)* | 1.02 (1.00–1.05)* | 1.01 (0.99–1.03) | – |
| Waist circumference (cm) | 1.01 (0.99–1.01) | 1.01 (0.99–1.01) | 1.00 (0.99–1.01) | 1.00 (0.99–1.01) |
| SBP (mmHg) | 1.00 (0.99–1.01)* | 1.01 (1.00–1.01)* | 1.00 (0.99–1.01) | 1.00 (0.99–1.01) |
| DBP (mmHg) | 1.01 (1.00–1.02)* | 1.01 (1.00–1.02)* | 1.00 (0.99–1.01) | 1.00 (0.99–1.01) |
| TG/HDL-C | 1.05 (0.98–1.13) | 1.05 (0.98–1.13) | 1.03 (0.96–1.11) | 1.02 (0.95–1.10) |
| Type 2 diabetes | 1.07 (0.75–1.53) | 1.06 (0.74–1.52) | 1.03 (0.72–1.48) | 1.05 (0.73–1.50) |
| Women ( | ||||
| BMI (kg/m2) | 1.02 (0.99–1.05) | 1.02 (0.99–1.05) | 1.00 (0.97–1.03) | – |
| Waist circumference (cm) | 1.01 (1.00–1.02)* | 1.01 (1.00–1.02)* | 1.00 (0.99–1.01) | 1.00 (0.99–1.01) |
| SBP (mmHg) | 0.99 (0.98–1.00) | 0.99 (0.98–1.00) | 0.99 (0.98–1.00) | 0.99 (0.99–1.00) |
| DBP (mmHg) | 0.99 (0.99–1.00) | 0.99 (0.99–1.00) | 0.99 (0.98–1.00) | 0.99 (0.99–1.00) |
| TG/HDL-C | 1.01 (0.97–1.04) | 1.01 (0.97–1.04) | 0.99 (0.96–1.04) | 0.99 (0.95–1.03) |
| Type 2 diabetes | 1.34 (1.01–1.79)* | 1.33 (1.00–1.78)* | 1.38 (1.03–1.84)* | 1.23 (0.92–1.64) |
Model 1, adjusted for age
Model 2, adjusted for factors in model 1 + SES
Model 3, adjusted for factors in model 2 + index individual’s risk factor + FH-DM + PAL. Models including blood pressure (SBP and DBP) or lipid levels (TG/HDL-C) were further adjusted for antihypertensive and lipid-lowering medication, respectively
Model 4, adjusted for factors in model 3 + index individual’s BMI
Models including type 2 diabetes, as exposure, were adjusted for the value of index individual’s FPG
*Significant results at the level of 0.05
BMI body mass index, FH-DM family history of diabetes mellitus, PAL physical activity level, FPG fasting plasma glucose, SBP systolic blood pressure, DBP diastolic blood pressure, TG/HDL-C triglyceride to high-density lipoprotein cholesterol ratio, SES socioeconomic status defined as the highest level of educational attainment, at the couple level